Atai Life Sciences N.V. - Laporan Laba Rugi (TTM)

Atai Life Sciences N.V.
DE ˙ XTRA ˙ NL0015000DX5
€ 3.83 ↑0.03 (0.76%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Atai Life Sciences N.V. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 20 20 20 20 0 1 0 0 0 0 0 0 0 0 0 0 2 2
Change (%) 0.00 1.34 1.14 -97.57 34.27 -36.19 -45.18 15.88 0.74 22.79 -5.99 -11.78 36.46 -12.43 -6.95 504.87 23.94
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales -5 11 -0
Change (%)
% of Revenue -24.73 4,054.15 -21.04
Gross Operating Profit 20 25 20 20 0 1 0 0 0 0 0 0 -11 0 0 0 2 2
Change (%) 24.73 -18.75 1.14 -97.57 34.27 -36.19 -45.18 15.88 0.74 22.79 -5.99 -3,588.22 -103.45 -12.43 -6.95 632.14 2.39
% of Revenue 100.00 124.73 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 -3,954.15 100.00 100.00 100.00 121.04 100.00
SG&A 88 123 139 93 101 81 80 70 65 66 58 62 61 58 56 46 45 46
Change (%) 38.99 12.96 -33.21 9.39 -19.82 -1.04 -12.61 -7.69 1.14 -11.56 7.05 -2.60 -4.89 -2.72 -17.97 -2.11 1.14
% of Revenue 444.85 618.29 689.23 455.17 20,454.44 12,213.81 18,941.18 30,193.13 24,051.11 24,145.59 17,391.02 19,803.18 21,865.34 15,239.42 16,930.51 14,925.00 2,415.51 1,971.16
R&D 15 33 38 48 58 60 65 74 76 76 69 60 43 50 50 54 54 52
Change (%) 121.81 16.36 25.13 20.59 3.33 9.48 13.60 2.72 -0.88 -9.43 -11.85 -28.94 15.98 0.98 7.64 0.00 -3.17
% of Revenue 74.69 165.68 190.24 235.36 11,659.48 8,972.07 15,392.71 31,893.99 28,271.85 27,816.54 20,515.87 19,236.62 15,495.31 13,169.84 15,187.01 17,568.51 2,904.51 2,269.16
OpEx 103 151 177 141 159 141 146 145 141 141 127 123 115 107 106 100 99 98
Change (%) 46.14 17.39 -20.59 13.21 -11.42 3.42 -0.86 -2.34 0.05 -10.42 -3.18 -6.42 -6.39 -1.00 -5.86 -1.36 -0.82
% of Revenue 519.55 759.25 879.47 690.52 32,113.91 21,185.89 34,333.88 62,087.12 52,322.96 51,962.13 37,906.89 39,039.81 41,414.80 28,409.26 32,117.52 32,493.51 5,298.98 4,240.32
Operating Income -83 -131 -157 -120 -159 -140 -145 -144 -141 -141 -126 -122 -114 -107 -106 -100 -97 -96
Change (%) 57.13 19.82 -23.38 31.97 -11.56 3.60 -0.73 -2.37 0.04 -10.48 -3.17 -6.40 -6.49 -0.96 -5.86 -2.92 -1.30
% of Revenue -419.55 -659.25 -779.47 -590.52 -32,013.91 -21,085.89 -34,233.88 -61,987.12 -52,222.96 -51,862.13 -37,806.89 -38,939.81 -41,314.80 -28,309.26 -32,017.52 -32,393.51 -5,198.98 -4,140.32
Interest Expense -0 -0 -1 -2 -2 -3 -3 -3 -3 -3 -3 -3 -3
Change (%) -14.53 67.39 42.59 31.09 -8.03 2.45 1.58 3.55 9.15 6.82 -13.10
% of Revenue -1.18 -0.99 -396.14 -572.22 -809.93 -864.67 -845.86 -982.31 -731.22 -864.65 -1,014.29 -179.12 -125.60
Net Income -185 -218 -166 -168 -205 -194 -196 -152 -149 -145 -67 -40 -34 -58 -129 -149 -149 -119
Change (%) 17.31 -23.92 1.38 22.38 -5.77 1.41 -22.35 -2.45 -2.40 -53.86 -39.91 -15.97 71.80 121.46 16.07 -0.19 -19.86
% of Revenue -932.88 -1,094.38 -821.63 -823.56 -41,404.23 -29,057.36 -46,176.71 -65,401.29 -55,055.93 -53,336.76 -20,042.81 -12,810.19 -12,202.89 -15,362.70 -38,852.87 -48,463.96 -7,997.16 -5,171.24

Source: Capital IQ

Other Listings
US:ATAI US$ 4.57
MX:ATAI N
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista